Filtered By:
Specialty: Drugs & Pharmacology
Procedure: Coronary Artery Bypass Graft
This page shows you your search results in order of date. This is page number 2.
Order by Relevance | Date
Total 48 results found since Jan 2013.
Safety and Efficacy of Tirofiban Bridging Therapy During a Hybrid Carotid Artery Stenting and Off-Pump Coronary Artery Bypass Grafting Surgery: A Single-Center Study
This study evaluated the safety and efficacy of tirofiban as a bridging therapy after a hybrid CAS + CABG surgery.METHODS: Between June 2018 and February 2022, a total of 45 patients undergoing a hybrid CAS + off-pump CABG surgery were divided into either the control group (standard dual antiplatelet therapy postsurgery, n = 27) or the tirofiban group (tirofiban bridging + dual antiplatelet therapy, n = 18). The 30-day outcome was compared between the 2 groups, and the primary end points included stroke, postoperative myocardial infarction, and death.FINDINGS: Two patients (7.41%) from the control group experienced a strok...
Source: Clinical Therapeutics - February 21, 2023 Category: Drugs & Pharmacology Authors: Changcheng Liu Shipan Wang Yuan Xue Jiantao Wang Haiyang Li Source Type: research
Use of CHA2DS2-VASc score to predict the risk of ischemic stroke and mortality in patients who underwent coronary artery bypass grafting surgery: a retrospective cohort study
CONCLUSIONS: Ischemic stroke was associated with a higher mortality risk after CABG. Higher CHA2DS2-VASc scores were associated with higher ischemic stroke risk. POAF did not significantly affect the relationship between CHA2DS2-VASc scores and ischemic stroke. CHA2DS2-VASc score can be used to predict ischemic stroke and mortality following CABG.PMID:36734704 | DOI:10.26355/eurrev_202301_31062
Source: European Review for Medical and Pharmacological Sciences - February 3, 2023 Category: Drugs & Pharmacology Authors: B D üzel Source Type: research
